MORGAN STANLEY - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$13,009,717
+27.7%
338,883
-36.9%
0.00%0.0%
Q2 2023$10,187,953
+189.3%
537,056
+136.5%
0.00%
Q1 2023$3,522,182
+16.6%
227,091
+33.4%
0.00%
Q4 2022$3,021,939
+485.6%
170,250
+84.2%
0.00%
Q3 2022$516,000
-17.0%
92,431
-42.1%
0.00%
Q2 2022$622,000
-50.5%
159,671
-30.0%
0.00%
Q1 2022$1,256,000
-70.3%
228,022
-54.1%
0.00%
-100.0%
Q4 2021$4,234,000
-43.7%
496,910
-42.6%
0.00%0.0%
Q3 2021$7,519,000
-53.9%
865,246
-43.9%
0.00%
-50.0%
Q2 2021$16,303,000
+35.0%
1,542,372
+104.9%
0.00%0.0%
Q1 2021$12,072,000
+240.4%
752,651
+880.4%
0.00%
+100.0%
Q4 2020$3,546,000
+1766.3%
76,769
+1328.5%
0.00%
Q3 2020$190,000
+12.4%
5,374
-22.6%
0.00%
Q2 2020$169,000
-46.2%
6,943
-65.6%
0.00%
Q1 2020$314,000
+1862.5%
20,176
+1917.6%
0.00%
Q4 2019$16,0001,0000.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders